Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1410]

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple-negative breast cancers

AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple...

AACR 2015: HPV vaccine provides protection at multiple sites, even among some previously exposed

AACR 2015: HPV vaccine provides protection at multiple sites, even among some previously exposed

AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes

AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer...

AACR 2015: Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

AACR 2015: Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer...

AACR 2015: Adding a dual mTOR inhibitor to chemo may benefit some ovarian and lung cancer patients

AACR 2015: Adding a dual mTOR inhibitor to chemo may benefit some ovarian and lung cancer patients

AACR 2015: CART-meso immunotherapy feasible for patients with advanced cancers

AACR 2015: CART-meso immunotherapy feasible for patients with advanced cancers

HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer

HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer

Risk of breast and ovarian cancer may differ by type of BRCA1, BRCA2 mutation

Risk of breast and ovarian cancer may differ by type of BRCA1, BRCA2 mutation

More from ecancer